Submit Content
Get the latest delivered to your inbox
Privacy Policy

Novo Nordisk

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. We believe that a healthy economy, environment and society are fundamental to long-term value creation. This is why we manage our business in accordance with the Triple Bottom Line business principle and consider the financial, environmental and social impact of our business decisions. The strategic commitment to corporate sustainability has brought the company onto centre stage as a leading player in today's business environment, recognised for its integrated reporting, stakeholder engagement and consistently high sustainability performance.

Novo Nordisk Joins RE100 with 100% Renewable Ambition  Image

POSTED 

12-07-15

Novo Nordisk Joins RE100 with 100% Renewable Ambition

Novo Nordisk has joined RE100 with an ambition to use 100% renewable electricity at all its global production sites by 2020. By joining the RE100, Novo Nordisk together with more than 50 global companies, is working to increase corporate demand for renewable energy.

“Switching to renewable...

In Indonesia, Novo Nordisk is Diabetes CSR Company of the Year Image

POSTED 

10-02-15

In Indonesia, Novo Nordisk is Diabetes CSR Company of the Year

For the second straight year, the global research company Frost & Sullivan has named Novo Nordisk Indonesia the Diabetes CSR Company of the Year. The acknowledgement recognises the company’s commitment and collaboration to improve care for the six million people wi...

Novo Nordisk Discusses Link Between Diabetes and Sustainable Development Image

POSTED 

09-17-15

Novo Nordisk Discusses Link Between Diabetes and Sustainable Development

Next week, world leaders will launch a new round of goals, targets and indicators to pick up where the Millennium Development Goals left off. In the new issue of Novo Nordisk’s sustainability magazine – T...

Novo Nordisk Remains in Top of 2015 Dow Jones Sustainability World Index Image

POSTED 

09-10-15

Novo Nordisk Remains in Top of 2015 Dow Jones Sustainability World Index

Novo Nordisk stays in top of the pharmaceutical sector on the 2015 Dow Jones Sustainability World Index with a score of 81 out of a possible 100. The company’s overall score falls 3 points from 2014 and is 7 points behind Roche, the 2015 industry leader.

The 2015 ranking marks the 16t...

Diabetes Screening in Kenya "“ ‘It Takes Only 5 Seconds’ Image

POSTED 

07-06-15

Diabetes Screening in Kenya "“ ‘It Takes Only 5 Seconds’

The Kenyan Ministry of Health, together with Novo Nordisk and the Kenya Diabetes Management and Information Centre, launched a six-month diabetes awareness campaign in Nairobi to promote early diagnosis through screening, especially among low-income populations. The ca...

Three Years in a Row: Novo Nordisk In Turkey Recognised for Ethical Conduct Image

POSTED 

06-15-15

Three Years in a Row: Novo Nordisk In Turkey Recognised for Ethical Conduct

For the third consecutive year, Novo Nordisk Turkey received the Turkish Ethics Award, ETÄ°KA 2014, for high ethical business conduct. The ETÄ°KA Award aims to recognise and publicly praise companies who value ethics and who are committed to operating in adherence to ethics and business morals, a...

Novo Nordisk #15 on Top Green Companies in the World Image

POSTED 

06-09-15

Novo Nordisk #15 on Top Green Companies in the World

In one of the foremost assessments of corporate environmental performance, Novo Nordisk moved up 12 places to rank #15 on the 2...

Novo Nordisk in the US "“ Teaming Up to Change Diabetes Image

POSTED 

06-03-15

Novo Nordisk in the US "“ Teaming Up to Change Diabetes

Today, Novo Nordisk published a new issue of its quarterly sustainability magazine, TBL Quarterly with focus on the US. Diabetes affects 29 million people in the US and is changing the health of its citizens and putting pressure on the delivery of healthcare. Making a ...

New Study: 1.5 Billion Dollars Could be Saved by Reducing Complications for People with Diabetes in Russia Image

POSTED 

04-09-15

New Study: 1.5 Billion Dollars Could be Saved by Reducing Complications for People with Diabetes in Russia

The challenge of diabetes continues to grow in Russia where 4 million people are diagnosed and even more are unaware of their condition. A new case study shows how Novo Nordisk together with partners is addressing this challenge and outlines...

Type 1 Diabetes - In Search of a Cure Image

POSTED 

03-18-15

Type 1 Diabetes - In Search of a Cure

Since Novo Nordisk was founded more than 90 years ago, the company has been committed to improving the lives of people with diabetes. Nothing would change the life of a child with type 1 diabetes more than a cure for this lifelong serious condition, but is a cure just a dream – or a po...

Novo Nordisk logo

Novo Nordisk

Novo Nordisk

Join today and get the latest delivered to your inbox